DENTSPLY SIRONA (NASDAQ:XRAY) Receives “Outperform” Rating from Barrington Research

DENTSPLY SIRONA (NASDAQ:XRAY)‘s stock had its “outperform” rating reiterated by Barrington Research in a note issued to investors on Tuesday,Benzinga reports. They currently have a $14.00 target price on the medical instruments supplier’s stock. Barrington Research’s price objective would indicate a potential upside of 24.47% from the company’s previous close.

A number of other brokerages have also recently commented on XRAY. Mizuho set a $13.00 target price on shares of DENTSPLY SIRONA in a report on Friday, November 7th. Evercore ISI decreased their target price on DENTSPLY SIRONA from $17.00 to $13.00 and set an “in-line” rating on the stock in a report on Wednesday, October 8th. Barclays began coverage on DENTSPLY SIRONA in a research report on Monday, December 8th. They set an “underweight” rating and a $12.00 target price on the stock. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of DENTSPLY SIRONA in a research note on Wednesday, October 8th. Finally, Robert W. Baird cut their price objective on DENTSPLY SIRONA from $14.00 to $12.00 and set a “neutral” rating for the company in a research note on Tuesday. Two investment analysts have rated the stock with a Buy rating, ten have assigned a Hold rating and three have assigned a Sell rating to the company’s stock. According to MarketBeat.com, DENTSPLY SIRONA has a consensus rating of “Reduce” and a consensus price target of $15.15.

DENTSPLY SIRONA Stock Performance

Shares of XRAY traded down $0.15 during trading hours on Tuesday, hitting $11.25. The stock had a trading volume of 349,553 shares, compared to its average volume of 3,133,010. The firm has a market capitalization of $2.24 billion, a PE ratio of -2.55, a PEG ratio of 0.85 and a beta of 1.01. The company has a debt-to-equity ratio of 1.36, a current ratio of 1.47 and a quick ratio of 0.99. DENTSPLY SIRONA has a 12 month low of $9.85 and a 12 month high of $20.59. The stock has a fifty day moving average price of $11.73 and a 200 day moving average price of $13.70.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its earnings results on Thursday, November 6th. The medical instruments supplier reported $0.37 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.45 by ($0.08). DENTSPLY SIRONA had a positive return on equity of 17.10% and a negative net margin of 24.34%.The firm had revenue of $904.00 million during the quarter, compared to analysts’ expectations of $900.33 million. During the same period in the previous year, the business posted $0.50 earnings per share. The company’s revenue for the quarter was down 4.9% on a year-over-year basis. DENTSPLY SIRONA has set its FY 2025 guidance at 1.600-1.600 EPS. Analysts anticipate that DENTSPLY SIRONA will post 1.84 EPS for the current year.

Insider Activity

In related news, Director Gregory T. Lucier sold 82,200 shares of the business’s stock in a transaction dated Monday, December 8th. The stock was sold at an average price of $11.14, for a total value of $915,708.00. The transaction was disclosed in a filing with the SEC, which is available through this link. Company insiders own 0.52% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of XRAY. Brooklyn Investment Group bought a new stake in shares of DENTSPLY SIRONA during the 1st quarter worth approximately $26,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. purchased a new stake in DENTSPLY SIRONA in the first quarter worth $26,000. Trust Co. of Toledo NA OH bought a new stake in shares of DENTSPLY SIRONA during the second quarter worth $27,000. Parkside Financial Bank & Trust boosted its stake in shares of DENTSPLY SIRONA by 620.6% during the second quarter. Parkside Financial Bank & Trust now owns 1,715 shares of the medical instruments supplier’s stock valued at $27,000 after purchasing an additional 1,477 shares during the period. Finally, Huntington National Bank grew its holdings in shares of DENTSPLY SIRONA by 292.9% in the third quarter. Huntington National Bank now owns 2,786 shares of the medical instruments supplier’s stock worth $35,000 after purchasing an additional 2,077 shares during the last quarter. 95.70% of the stock is owned by hedge funds and other institutional investors.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.